Cytosine modifications modulate the chromatin architecture of transcriptional enhancers.

Epigenetic mechanisms are believed to play key roles in the establishment of cell-specific transcription programs. Accordingly, the modified bases 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) have been observed in DNA of genomic regulatory regions such as enhancers, and oxidation of 5mC into 5hmC by Ten-eleven translocation (TET) proteins correlates with enhancer activation. However, the functional relationship between cytosine modifications and the chromatin architecture of enhancers remains elusive. To gain insights into their function, 5mC and 5hmC levels were perturbed by inhibiting DNA methyltransferases and TETs during differentiation of mouse embryonal carcinoma cells into neural progenitors, and chromatin characteristics of enhancers bound by the pioneer transcription factors FOXA1, MEIS1, and PBX1 were interrogated. In a large fraction of the tested enhancers, inhibition of DNA methylation was associated with a significant increase in monomethylation of H3K4, a characteristic mark of enhancer priming. In addition, at some specific enhancers, 5mC oxidation by TETs facilitated chromatin opening, a process that may stabilize MEIS1 binding to these genomic regions.

[1]  Michael Weber,et al.  Single-CpG resolution mapping of 5-hydroxymethylcytosine by chemical labeling and exonuclease digestion identifies evolutionarily unconserved CpGs as TET targets , 2016, Genome Biology.

[2]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2016, Nucleic Acids Res..

[3]  Y. Homma,et al.  TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression , 2015, Nature Communications.

[4]  C. Glass,et al.  The selection and function of cell type-specific enhancers , 2015, Nature Reviews Molecular Cell Biology.

[5]  A. Regev,et al.  Pluripotency Transcription Factor Oct4 Mediates Stepwise Nucleosome Demethylation and Depletion , 2015, Molecular and Cellular Biology.

[6]  Makiko Iwafuchi‐Doi,et al.  Pioneer transcription factors in cell reprogramming , 2014, Genes & development.

[7]  S. Balasubramanian,et al.  5-Hydroxymethylcytosine is a predominantly stable DNA modification. , 2014, Nature chemistry.

[8]  Chongli Yuan,et al.  Hydroxymethylation of DNA influences nucleosomal conformation and stability in vitro. , 2014, Biochimica et biophysica acta.

[9]  Lee E. Edsall,et al.  5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. , 2014, Molecular cell.

[10]  J. Mallm,et al.  Nucleosome repositioning links DNA (de)methylation and differential CTCF binding during stem cell development , 2014, Genome research.

[11]  Rochelle L. Tiedemann,et al.  Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells , 2014, Genome Biology.

[12]  Huidong Shi,et al.  MBD3 Localizes at Promoters, Gene Bodies and Enhancers of Active Genes , 2013, PLoS genetics.

[13]  Peter A. Jones,et al.  Establishment of active chromatin structure at enhancer elements by mixed-lineage leukemia 1 to initiate estrogen-dependent gene expression , 2013, Nucleic acids research.

[14]  S. Balasubramanian,et al.  A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation , 2013, Genome Biology.

[15]  Razvan R. Popovici,et al.  Additional file 8 , 2010 .

[16]  E. Ballestar,et al.  PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation , 2013, Genome Biology.

[17]  W. V. van Cappellen,et al.  Enhanced chromatin dynamics by FACT promotes transcriptional restart after UV-induced DNA damage. , 2013, Molecular cell.

[18]  V. Rybin,et al.  Structural basis of histone H2A–H2B recognition by the essential chaperone FACT , 2013, Nature.

[19]  F. Lienert,et al.  Methylation-Dependent and -Independent Genomic Targeting Principles of the MBD Protein Family , 2013, Cell.

[20]  A. Bird.  The dinucleotide CG as a genomic signalling module , 2013, Epigenetics & Chromatin.

[21]  J. Wysocka,et al.  Modification of enhancer chromatin: what, how, and why? , 2013, Molecular cell.

[22]  A. H. Smits,et al.  Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives , 2013, Cell.

[23]  F. Tashiro,et al.  Involvement of Crosstalk between Oct4 and Meis1a in Neural Cell Fate Decision , 2013, PloS one.

[24]  Carlos Caldas,et al.  Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. , 2013, Cell reports.

[25]  A. Viale,et al.  RAR&ggr; is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells , 2013, Journal of Cell Science.

[26]  M. Scharfe,et al.  Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences , 2013, Nucleic acids research.

[27]  E. Furlong,et al.  Transcription factors: from enhancer binding to developmental control , 2012, Nature Reviews Genetics.

[28]  J. Eeckhoute,et al.  Dynamic hydroxymethylation of deoxyribonucleic acid marks differentiation-associated enhancers , 2012, Nucleic acids research.

[29]  Yongjun Tan,et al.  Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells. , 2012, Gene expression.

[30]  David A. Orlando,et al.  Enhancer decommissioning by LSD1 during embryonic stem cell differentiation , 2012, Nature.

[31]  Poshen B. Chen,et al.  Mbd3/NURD Complex Regulates Expression of 5-Hydroxymethylcytosine Marked Genes in Embryonic Stem Cells , 2011, Cell.

[32]  Vijay K. Tiwari,et al.  DNA-binding factors shape the mouse methylome at distal regulatory regions , 2011, Nature.

[33]  Akane Kawamura,et al.  Inhibition of 2‐Oxoglutarate Dependent Oxygenases , 2011 .

[34]  Mathieu Lupien,et al.  PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer , 2011, PLoS genetics.

[35]  Yang Wang,et al.  Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA , 2011, Science.

[36]  A. Maiti,et al.  Thymine DNA Glycosylase Can Rapidly Excise 5-Formylcytosine and 5-Carboxylcytosine , 2011, The Journal of Biological Chemistry.

[37]  Clifford A. Meyer,et al.  Cistrome: an integrative platform for transcriptional regulation studies , 2011, Genome Biology.

[38]  C. Schofield,et al.  Inhibition of 2-oxoglutarate dependent oxygenases. , 2011, Chemical Society reviews.

[39]  Myong-Hee Sung,et al.  Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. , 2011, Molecular cell.

[40]  A. Bird.  The dinucleotide CG as a genomic signalling module , 2011, Journal of molecular biology.

[41]  S. Mandrup,et al.  Extensive chromatin remodelling and establishment of transcription factor ‘hotspots’ during early adipogenesis , 2011, The EMBO journal.

[42]  J. Eeckhoute,et al.  Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. , 2011, Genome research.

[43]  S. Robson,et al.  Nucleosome-Interacting Proteins Regulated by DNA and Histone Methylation , 2010, Cell.

[44]  Hong Zhu,et al.  Increased levels of FoxA1 transcription factor in pluripotent P19 embryonal carcinoma cells stimulate neural differentiation. , 2010, Stem cells and development.

[45]  J. Ragoussis,et al.  Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. , 2010, Immunity.

[46]  Michael D. Wilson,et al.  ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. , 2009, Methods.

[47]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[48]  Uma M. Muthurajan,et al.  Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA. , 2009, Genes & development.

[49]  M. García-Cuéllar,et al.  Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2 , 2009, Oncogene.

[50]  Clifford A. Meyer,et al.  Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. , 2008, Genome research.

[51]  S. Ratcliffe,et al.  GEEQBOX: A MATLAB Toolbox for Generalized Estimating Equations and Quasi-Least Squares , 2008 .

[52]  Clifford A. Meyer,et al.  FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription , 2008, Cell.

[53]  Sébastien Lê,et al.  FactoMineR: An R Package for Multivariate Analysis , 2008 .

[54]  B. Black,et al.  Determinants of Myogenic Specificity within MyoD Are Required for Noncanonical E Box Binding , 2007, Molecular and Cellular Biology.

[55]  V. Iyer,et al.  FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. , 2007, Genome research.

[56]  Inna Dubchak,et al.  VISTA Enhancer Browser—a database of tissue-specific human enhancers , 2006, Nucleic Acids Res..

[57]  L. Selleri,et al.  Hox cofactors in vertebrate development. , 2006, Developmental biology.

[58]  D. Soprano,et al.  Pre-B Cell Leukemia Transcription Factor (PBX) Proteins Are Important Mediators for Retinoic Acid-dependent Endodermal and Neuronal Differentiation of Mouse Embryonal Carcinoma P19 Cells* , 2004, Journal of Biological Chemistry.

[59]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[60]  M. Birke,et al.  The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. , 2002, Nucleic acids research.

[61]  N. Copeland,et al.  Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins , 1997, Molecular and cellular biology.

[62]  C. Largman,et al.  The Abd-B-like Hox Homeodomain Proteins Can Be Subdivided by the Ability to Form Complexes with Pbx1a on a Novel DNA Target* , 1997, The Journal of Biological Chemistry.

[63]  R. Jaenisch,et al.  Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[65]  W. Liang,et al.  9) TM4 Microarray Software Suite , 2006 .

[66]  Doree Sitkoff,et al.  models homology modeling : From sequence alignments to structural A comparative study of available software for high-accuracy , 2005 .